Evaluation of supported self-management in gout (GoutSMART): a randomised controlled feasibility trial

痛风 医学 物理疗法 自我管理 介绍 随机对照试验 别嘌呤醇 内科学 家庭医学 计算机科学 机器学习
作者
Philip L. Riches,Debbie Alexander,Barbara Hauser,Barbara Kuske,Amrey Krause
出处
期刊:The Lancet Rheumatology [Elsevier BV]
卷期号:4 (5): e320-e328 被引量:31
标识
DOI:10.1016/s2665-9913(22)00062-5
摘要

Background Improved outcomes for patients with gout are associated with the control of urate levels; yet, less than 40% of patients in the UK are currently offered urate lowering therapy, and it is typically offered without titration to target. Supported self-management has been shown to benefit patients with chronic health conditions; therefore, we aimed to determine whether a supported gout self-management approach, incorporating treatment-to-target urate, helped participants reach target urate levels. Methods In this randomised controlled feasibility study, conducted in one hospital in Edinburgh, UK, we included patients (aged ≥18 years) with gout and a physician recommendation for initiation or escalation of urate lowering therapy. We randomised participants in a 2:1 ratio to a supported self-management group or a usual care group using the GoutSMART smartphone app. Participants in the self-management group were given a urate self-testing meter and received direct advice from clinicians on escalation of urate lowering therapy through the app. Participants were identified following referral to rheumatology, or using the Scottish Health Research Register, and they were screened and offered a detailed management plan before randomisation. Participants in the usual care group had a limited version of the app, which only allowed it to function as a health diary, and their gout management plan was implemented by their general practitioner. The primary outcome was the percentage of participants achieving a urate target of 0·30 mmol/L or less at 24 weeks, and analysis was by intent to treat. The trial was registered with ClinicalTrials.gov, NCT03274063, and there is an extension study ongoing. There was no masking of participants or assessors. Findings Between April 5, 2019, and March 19, 2020, 60 (65%) of 92 patients screened were enrolled to the study. The mean age was 52.8 years (SD 14.6); 56 (93%) of the participants were male, and 4 (7%) were female. 58 (97%) of participants were White. 40 participants were assigned to the self-supported management group and 20 participants were assigned to the usual care group. A urate target of 0·30 mmol/L or less at 24 weeks was reached by 29 (73%) participants in the supported self-management group compared with 3 (15%) participants in the usual care group (risk difference 0·58 [95% CI 0·37–0·78]; p<0·0001). 90% of participants completed the study with no difference in the drop-out rate or adverse events between the two groups. Interpretation Supported self-management of gout results in substantially improved attainment of urate targets compared with usual care, and it is well tolerated. Larger trials will be needed to fully evaluate the clinical and cost-effectiveness of this approach. Funding Edinburgh & Lothians Health Foundation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
知晏完成签到,获得积分20
1秒前
1秒前
1秒前
1秒前
碎觉觉发布了新的文献求助10
1秒前
QA发布了新的文献求助10
1秒前
Maestro_S的应助被酷炫傲安采纳,获得30
1秒前
vin发布了新的文献求助10
1秒前
tiantianyuan完成签到 ,获得积分10
1秒前
beok完成签到,获得积分10
1秒前
1秒前
如初发布了新的文献求助10
2秒前
2秒前
2秒前
2秒前
3秒前
3秒前
丰川祥子发布了新的文献求助10
3秒前
3秒前
mrx96完成签到 ,获得积分10
3秒前
4秒前
Owen的应助被clyj采纳,获得10
4秒前
炙热的穆发布了新的文献求助10
4秒前
mike2012发布了新的文献求助10
4秒前
4秒前
4秒前
科研通AI6.3的应助被raven采纳,获得10
5秒前
CodeCraft的应助被yftan采纳,获得10
5秒前
li完成签到,获得积分10
7秒前
7秒前
7秒前
QINJINGRUI发布了新的文献求助10
7秒前
QDU的应助被l卢采纳,获得10
7秒前
7秒前
唐唐发布了新的文献求助10
7秒前
8秒前
jindex发布了新的文献求助10
8秒前
阳光奎完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175695
求助须知:如何正确求助?哪些是违规求助? 9567289
关于积分的说明 21792006
捐赠科研通 7770255
什么是DOI,文献DOI怎么找? 3431873
关于科研通互助平台的介绍 2556250
邀请新用户注册赠送积分活动 2477335